Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission

Levine SR, Welch KMA: The Spectrum of Neurologic Disease Associated with Antiphospholipid Antibodies, Lupus Anticoagulant, and Anticardiolipin Antibodies. Arch Neurol 44: 876–883, 1987 Schleider M: A clinical study of the lupus anticoagulant. Blood 48: 499–509, 1976 Asherson RA, Harris EN: Anticardiolipin antibodies. Clin Assoc Postgraduate Medical Journal 62: 1081–1087, 1986 Digre KB et al.: Amaurosis fugax with antiphospholipid antibodies. Ann Neurol 25: 228–232, 1989 Feldman E, Posner JB: Episodic neurologic dysfunction in patients with Hodgkin's Disease. Arch Neurol 43: 1227–1233, 1986 Case Records: Massachusetts General Hospital. NEJM 319:699–712,1988 Green O et al.: Report of the Working Party on acquired inhibitors of coagulation: Studies of the ‘lupus’ anticoagulant. Thrombo Haemostas 49: 144–146, 1983 Graus F et al.: Cerebrovascular complications — Patients with cancer. Medicine 64: 16–35, 1985 Triplett DA et al.: The relationship between lupus anti-coagulants and antibodies to phospholipid. JAMA 259: 550–554,1988 Mueh JR, Herbst KD, Rappaport SI: Thrombosis in patients with the lupus anticoagulant. Ann Int Med 144: 510–515, 1984 Fisher M, McGehee W: Cerebral infarct, TIA, and lupus inhibitor. Neurology 36: 1234–1237, 1986 Briley DP, Coull M, Goodnight Jr SH: Neurological disease associated with antiphospholipid antibodies. Ann Neurol 25: 221–227, 1989 Petrie M et al.: The frequency of lupus anticoagulants in SLE. Ann Int Med 106: 524–531, 1987 Carreras LO, Vermylen JG: Lupus anticoagulant and thrombosis possible role of inhibition of prostacylin formation. Thromb Haem 48: 28–40, 1982